As we approach the kickoff of the 2024 ASCO Annual Meeting, we are taking a look at some of the “can’t miss” sessions, symposiums, presentations and more, specific to lung cancer. This includes Non-Small-Cell Lung Cancer (NSCLC) and Small-Cell Lung Cancer (SCLC), and both early and metastatic.

Before we dive in, if you are an oncologist, or any clinician dealing with cancer care, and you don’t have your tickets yet, we strongly suggest grabbing those ASAP and booking your travel plans, because rooms for the ASCO Annual Conference often sell out quickly! Click here to see tickets, travel details, full program information, and more for ASCO24.

Below is a list of some of the “can’t miss” sessions at ASCO 2024 for Lung Cancer, including NSCLC and SCLC. The list is in chronological order for your convenience:

Lung Cancer—Non-Small Cell Metastatic
Date: 5/31/24 @ 2:45 PM
Location: Arie Crown Theater
Type: Oral Abstract Session
Presenters summarize their novel research findings and provide background on their methodologies. Discussants analyze the significance of each abstract within the context of current knowledge, highlighting clinical application and implications for future research and practice. Abstract presenters and discussants answer questions during a moderated panel discussion.

New Frontiers in Lung Cancer Treatment: Expanding Options Beyond Chemoimmunotherapy
Date: 6/1/24 @ 9:00 AM
Location: Arie Crown Theater
Type: Education Session
This session will explore the benefits of docetaxel following first-line chemoimmunotherapy in patients with non-small cell lung cancer, as well as emerging therapies that may signal an alternative to that approach. Novel cellular therapies, bispecific antibodies, and vaccines will be discussed, and considerations for patients who are older, with poor performance status, or who have had prior immune-related toxicities will be explored.

Targeting KRAS in Non–Small Cell Lung Cancer
Date: 6/1/24 @ 1:15 PM
Location: Hall B1
Type: Clinical Science Symposium
The session will begin with a foundational presentation on the session topic to set the stage for the abstracts to follow. Abstract presenters summarize research findings, while discussants place the abstracts in the appropriate context with a focus on how the findings apply to clinical practice. Abstracts in these sessions may span disease sites or disciplines, but they are unified by their focus on a key scientific topic.

Advanced Lung Cancer: State-of-the-Art Approaches and Insights
Date: 6/1/24 @ 3 PM
Location: S406
Type: Education Session
This session will review current state-of-the-art approaches and recent advances in the care of patients with metastatic small cell and non-small cell lung cancer. Strategies for selecting an appropriate therapy for patients with different disease subtypes will also be discussed.

Lung Cancer—Non-Small Cell Metastatic
Date: 6/1/24 @ 4:30 PM
Location: S406
Type: Rapid Oral Abstract
Presenters give an overview of their novel research and answer questions during a moderated panel discussion.

New Treatment Options for Patients With Oncogene-Addicted Non–Small Cell Lung Cancer
Date: 6/2/24 @ 8:00 AM
Location: S406
Type: Education Session
This session will review current and emerging first-line treatment options for patients with metastatic, EGFR-mutated NSCLC, as well as strategies to overcome resistance to EGFR-directed therapies. Use of tyrosine kinase inhibitors in patients with early-stage lung cancer with EGFR or ALK alterations will also be discussed.

Integrating Immunotherapy Into Early-Stage Lung Cancer
Date: 6/2/24 @ 9:45 AM
Location: Hall B1
Type: Education Session
Indications for the integration of immunotherapy in the treatment of patients with early-stage lung cancer will be evaluated. Optimal sequence of immunotherapy when considering other local therapies will be discussed, along with strategies for choosing among induction, adjuvant, and peri-operative approaches. Designing trials to address unmet needs in this field will also be explored.

Optimizing Treatment of Locally Advanced Non–Small Cell Lung Cancer: A Multimodal Approach in the Immunotherapy Era
Date: 6/2/24 @ 11:30 AM
Location: Hall D1
Type: Case-Based Panel
This session will explore how to choose between a surgical and non-surgical approach for patients with non-oncogene driven locally advanced NSCLC, with consideration of patient- and cancer-related factors. The role of adjuvant therapy will also be addressed, as well as therapeutic options for patients who do not undergo surgery.

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Date: 6/2/24 @ 4:30 PM
Location: S406
Type: Rapid Oral Abstract
Presenters give an overview of their novel research and answer questions during a moderated panel discussion.

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Date: 6/3/24 @ 8:00 AM
Location: Arie Crown Theater
Type: Oral Abstract Session
Presenters summarize their novel research findings and provide background on their methodologies. Discussants analyze the significance of each abstract within the context of current knowledge, highlighting clinical application and implications for future research and practice. Abstract presenters and discussants answer questions during a moderated panel discussion.

Of course, this is just a starting point, and there are additional sessions and events on topics such as:

  • Lung Cancer—Non-Small Cell Metastatic Poster Sessions in Hall A
  • Treating Lung Cancer in Young Adults: Considerations and Outcomes
  • Survivorship in Advanced Lung Cancer: Understanding a New Landscape and Opportunities
  • Hitting the Mark: The Ongoing Search for Immunotherapy Biomarkers
  • Prevention, Risk Reduction, and Genetics
  • And so much more in Lung Cancer at ASCO 2024!

Make sure to check out the conference recap post in June 2024 at the conclusion of the conference. In that follow up we will take a deeper dive into what was shared during the Conference specific to NSCLC and SCLC, and cover some of the key takeaways and highlights. You can also sign up for alerts and stay informed on the latest published guidelines and articles.

Copyright © 2024 Guideline Central, All rights reserved.